Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

辰欣药业 - NMPA Drug Approval Details

Approvals/NMPA/Betahistine Hydrochloride and Sodium Chloride Injection

Approved

化学药品

Betahistine Hydrochloride and Sodium Chloride Injection

辰欣药业股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Apr 24, 2020
Approval ID: 7LeaeBcLnOX
Company: 辰欣药业股份有限公司
Type: 化学药品

Approval Details

Approval Id: 7LeaeBcLnOX
Approval Number: 国药准字H20044033
Generic Name: 盐酸倍他司汀氯化钠注射液
Generic Name En: Betahistine Hydrochloride and Sodium Chloride Injection
Brand Name: 辰欣药业
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 500ml:盐酸倍他司汀0.02g与氯化钠4.5g
Reg Date: 2020-04-24
Company Name: 辰欣药业股份有限公司
Company Address: 济宁高新区同济科技工业园
Production Company Name: 辰欣药业股份有限公司
Production Company Address: 济宁高新区同济科技工业园（非PVC多层共挤输液袋）；济宁高新区海川路（玻璃输液瓶）
Company Detail Path: /organization/cisen-pharmaceutical-co-ltd
Production Company Detail Path: /organization/cisen-pharmaceutical-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Apr 24, 2020

Approval ID

7LeaeBcLnOX

Type

化学药品

Back to NMPA Approvals